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Abstract: Sodium hyaluronate (HA) was associated with dopamine (DPA) and introduced as 
a coating for maghemite (γ-Fe2O3) nanoparticles obtained by the coprecipitation of iron(II) and 
iron(III) chlorides and oxidation with sodium hypochlorite. The effects of the DPA anchor-
age of HA on the γ-Fe2O3 surface on the physicochemical properties of the resulting colloids 
were investigated. Nanoparticles coated at three different DPA-HA/γ-Fe2O3 and DPA/HA 
ratios were chosen for experiments with rat bone marrow mesenchymal stem cells and human 
chondrocytes. The nanoparticles were internalized into rat bone marrow mesenchymal stem 
cells via endocytosis as confirmed by Prussian Blue staining. The efficiency of mesenchymal 
stem cell labeling was analyzed. From among the investigated samples, efficient cell labeling 
was achieved by using DPA-HA-γ-Fe2O3 nanoparticles with DPA-HA/γ-Fe2O3 = 0.45 (weight/
weight) and DPA/HA = 0.038 (weight/weight) ratios. The particles were used as a contrast agent 
in magnetic resonance imaging for the labeling and visualization of cells.
Keywords: nanoparticles, dopamine, hyaluronate, cell labeling, magnetic
Introduction
Magnetic nanoparticles and nanowires are currently utilized in a wide variety of 
medical diagnostic and therapeutic applications such as hyperthermia, cell sorting, 
cell tracking and tissue engineering,1 as contrast agents for magnetic resonance 
imaging (MRI), and for the manipulation and spatial organization of cells.2 Cell 
labeling with magnetic nanoparticles is an increasingly common method for cell 
separation as well as for the repeated noninvasive monitoring of the migration and 
distribution of transplanted cells in the host tissue by MRI.3
As water in the tissue contains most of the protons, MRI in fact detects the 
  distribution of tissue water. However, MRI contrast can also be weighted by different 
physical properties of the detected water molecules, the most important of which are the 
so-called relaxation times T1, T2, or T2*, thus even native MRI (without the application 
of contrast agents) provides valuable information about the tissue. However, the resolu-
tion of MRI is too low to detect single cells, therefore it is necessary to label transplanted 
cells with a suitable contrast agent to enable their subsequent detection using MRI. 
Although MRI does not detect the contrast agent itself, contrast agents considerably 
alter the relaxation times of water in their vicinity and thus influence the contrast of 
the images. As a result, the size of the area impacted by a contrast agent is consider-
ably larger than the size of the contrast agent – or the size of the labeled cell – itself. 
Superparamagnetic nanoparticles create local inhomogeneities in a static field leading 
to the considerable shortening of T2 and T2* relaxation times and rapid signal loss. 
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1461
ORIgINAL RESEARCH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJN.S28658International Journal of Nanomedicine 2012:7
Their presence is therefore manifested by hypointense areas 
in a T2-weighted or T2*-weighted MRI.
Magnetic cell labeling could also aid cell-based therapies 
by directing stem cells to diseased locations4 and providing 
cell-based carriers to transport therapeutic genes to tumors.5 
Iron oxide nanoparticles, especially maghemite (γ-Fe2O3) 
ones, are the most suitable magnetic material because of their 
biocompatibility and their superparamagnetic properties. Iron 
oxide contained in endosomes and lysosomes is metabolized 
into elemental iron by hydrolytic enzymes.6 The advantage of 
iron is that the human body is designed to process excess iron, 
and it is stored mainly in the protein ferritin. For most in vivo 
applications, the efficient internalization of nanoparticles into 
specific cells requires the minimization of undesired biological 
interactions such as nonspecific targeting (plasma protein 
adsorption) and short blood lifespan due to opsonization, which 
induces the removal of the particles by the reticuloendothelial 
system. To achieve the efficient and specific cellular uptake 
of magnetic nanoparticles requires the nanoparticle surface 
to be modified with suitable ligands or transfection agents, 
which also enhances colloid stability and cell interactions. 
Surface modifications can also be used to minimize toxicity. 
Modifications of neat or dextran-coated iron oxide with 
human immunodeficiency virus-Tat peptide,7,8 dendrimers,9 
lipofection agents,10,11 poly(L-lysine),12–14 and carboxymethyl 
chitosan15 have recently been reported.
Hyaluronate (HA), a naturally occurring polysaccharide 
consisting of β-1,3-N-acetylglucosaminyl-β-1,4-glucuronide 
and having a molecular weight ranging from 1–10,000 kDa, 
is an abundant component of the extracellular matrix,16 the 
synovial fluid, and connective, epithelial, and neural tissues.17 
As a result of its ability to form hydrated expanded matrices, 
HA has often been used in cosmetic applications such as soft 
tissue augmentation. Moreover, in various studies HA has 
been utilized as a targeting ligand directed at cancer cells.18,19 
At the same time, HA-immobilized iron oxide   nanoparticles 
allow tumor tissue imaging. The advantage of HA for 
clinical applications is that it is biocompatible, antigenic, and 
negatively charged, thus forming ionic bonds with positively 
charged proteins to increase its affinity towards cells. The 
disadvantage of HA lies in its rapid resorption20,21 unless 
it is crosslinked or chemically modified. HA interacts with 
HA receptors such as CD44, RHAMM, and ICAM-1, which 
  triggers intracellular signals influencing cellular proliferation, 
differentiation, and migration.18
The aim of the present work was to explore the potential 
usefulness of dopamine (DPA) as an agent to anchor HA 
to the iron oxide surface, using different DPA/HA ratios in 
the formation of a biomimetic shell. The second aim was to 
investigate the effect of a DPA-HA coating on iron oxide 
nanoparticles in terms of cell behavior,   internalization, 
and differentiation, which could contribute to a better 
  understanding of cell–biomaterial interactions. The pivotal 
role of anchoring a DPA-HA conjugate on the nanoparticle 
surface via bioinspired adhesion in MRI and cellular uptake 
was already described by Lee et al.18 A key feature of DPA 
is the ortho-dihydroxyphenyl (catechol) functional group 
in planar ordering, which forms strong bonds with various 
inorganic (including transition metals)/organic surfaces 
that were shown to be stronger than biotin–streptavidin 
interactions.22 In contrast to Lee et al,18 who synthesized 
magnetic nanocrystals by the thermal decomposition of an 
iron oleate complex, which required their transfer to water 
using cetyltrimethylammonium bromide, the new approach 
in the present study uses γ-Fe2O3 nanoparticles prepared by 
a coprecipitation method in water and subsequent coating 
with a DPA-HA associate.
Material and methods
Materials
Iron(II) chloride tetrahydrate (FeCl2⋅4 H2O) and iron(III) 
chloride hexahydrate (FeCl3⋅6 H2O) were purchased 
from Fluka (Buchs, Switzerland), sodium hypochlorite 
  solution (NaClO) from Bochemie (Bohumin, Czech 
  Republic), and sodium citrate dihydrate from Lachema 
(Brno, Czech Republic). Sodium HA (molecular weight: 
∼300,000) was obtained from Contipro Pharma (Dolni 
Dobrouc, Czech Republic), DPA hydrochloride and N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
from Sigma-Aldrich Corporation (St Louis, MO), and the 
commercial contrast agent Endorem® from Guerbet (Roissy, 
France). Ultrapure Q-water ultrafiltered on a Milli-Q® 
  Gradient A10® system (Millipore SAS, Molsheim, France) 
was used throughout the work. All other reagent grade 
chemicals were purchased from Sigma-Aldrich and used as 
received. For histological staining, potassium ferrocyanide 
(Lachema) and Alcian Blue (Sigma-Aldrich) were used. 
Phosphate buffered saline (PBS) was from Sigma-Aldrich.
Association of HA with DPA
In a typical experiment, HA (0.402 g; 1 mmol) was   dissolved 
in 30 mL of Q-water and the solution purged with   nitrogen 
prior to the addition of N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (19 mg; 0.1 mmol) 
and DPA (19 mg; 0.1 mmol). The mixture was adjusted to 
pH 5 by the addition of 1 M hydrochloric acid and then the 
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reaction proceeded in darkness for 12 hours at laboratory 
temperature with stirring under a nitrogen atmosphere. As 
the resulting mixture was colorless, DPA was not oxidized 
during the   reaction. The DPA-HA associate was separated and 
purified by double precipitation in an excess of acetone. The 
precipitate was then dissolved in Q-water and freeze-dried.
Synthesis of γ-Fe2O3 nanoparticles
A solution of iron(II) chloride (0.2 mol/L) and iron(III) 
chloride (0.2 mol/L) in a 1:2 molar ratio was coprecipi-
tated in an excess of 0.5 M ammonium hydroxide by a 
  procedure described earlier.23 After 15 minutes, the product 
was repeatedly separated in a magnetic field and washed 
with Q-water to reach peptization. The colloid was subse-
quently sonicated for 5 minutes (Ultrasonic Homogenizer 
4710 series; Cole-Parmer Instruments, Vernon Hills, IL; 
40% output) and oxidized with 5 weight percent sodium 
hypochlorite aqueous solution in the presence of 0.1 M 
sodium citrate solution. The washing and sonication proce-
dures were then repeated. The resulting colloid was filtered 
through a   cellulose nitrate membrane filter with 0.45 µm 
pores. The colloid contained typically ∼40 mg γ-Fe2O3/mL 
as estimated by weight analysis.
Coating of γ-Fe2O3 nanoparticles  
with DPA-HA associate
A water solution (0.5, 1, or 2 mL) of lyophilized DPA-HA 
(10 mg/mL) was passed through a syringe filter with a 
  cellulose nitrate membrane (0.22 µm pores) and diluted with 
Q-water. Neat γ-Fe2O3 colloid (∼1 mL; 44 mg of dry γ-Fe2O3) 
was added to the diluted DPA-HA solution, the total volume 
was adjusted to 10 mL, and the mixture was sonicated for 
5 minutes. Coating with neat DPA and HA was done as a 
control.
Characterization of the nanoparticles
The hydrodynamic diameter (Dh), polydispersity (PI), and 
zeta potential were determined by dynamic light scattering 
with an Autosizer Lo-C® (Malvern Instruments, Malvern, 
United Kingdom). pH was measured on a pH meter (211; 
Hanna Instruments, Smithfield, RI) equipped with an 
Orion 9802BN micro-combination pH electrode (Balcatta, 
Australia). Particle morphology, particle size, and the 
particle size distribution were examined by a Spirit G2 
Tecnai™ transmission electron microscope (TEM; FEI, 
Brno, Czech Republic) by   measuring at least 300 particles 
for each sample. The particle size   distribution was charac-
terized by the polydispersity index (PDI), calculated as the 
ratio of weight-average to number-average particle diam-
eter. Elemental analysis was performed on a PerkinElmer 
2400 CHN apparatus (PerkinElmer, Waltham, MA). Size 
  exclusion chromatography was performed on a KNAUER 
Smartline 1000 system (KNAUER, Berlin, Germany) with a 
PDA Smartline 2800 detector and Alltech® 3300 evaporative 
light scattering detector (Grace Davison Discovery Sci-
ences, Deerfield, IL). Measurements were carried out on 
a TSKgel G6000PW column (Tosoh Bioscience GmbH, 
Stuttgart, Germany) using 0.3 M ammonium acetate buffer 
as an isocratic eluent.
Cell cultures
To isolate rat bone marrow mesenchymal stem cells (MSCs), 
femurs were dissected from 4-week-old Wistar rats. The 
ends of the bones were cut, and the marrow extruded with 
5 mL of Dulbecco’s Modified Eagle’s Medium (DMEM) 
with L-glutamine (PAA Laboratories GmbH, Pasching, 
Austria) using a needle and syringe. Marrow cells were 
plated in 80-cm2 tissue culture flasks in DMEM/10% fetal 
bovine serum with 100 U/mL penicillin and 0.1 mg/mL 
streptomycin. After 24 hours, the nonadherent cells were 
removed by replacing the medium. The medium was changed 
every 2–3 days as the cells grew to confluence. The cells 
were lifted by incubation with 0.25 weight percent trypsin 
solution.
As a second model, human chondrocytes isolated from 
human cartilage were used. Human chondrocytes were 
obtained from meniscal biopsies of the knee joint. Meniscal 
fragments were minced, washed with PBS, and digested in 
0.25% trypsin-ethylenediaminetetraacetic acid (Invitrogen 
Life Technologies, Paisley, United Kingdom) for 1 hour 
and subsequently in 0.25% collagenase type I in DMEM/
F12 medium overnight. Recovered cells were washed with 
PBS and plated in a 75-cm2 tissue culture flask in DMEM/
F12 medium containing 10% fetal bovine serum, 100 U/mL 
penicillin, and 0.1 mg/mL streptomycin.
Cell labeling, cell growth, and cell viability
Rat MSCs and human chondrocytes, 100,000 cells/mL 
media, were cultured in a twelve-well culture dish, and a 
colloid containing 15.4 µg of iron per mL of DPA-γ-Fe2O3, 
HA-γ-Fe2O3, DPA-HA-γ-Fe2O3, or Endorem was added; 
the incubation lasted for 48 hours. The nanoparticles were 
washed out using PBS and then the cells were harvested by 
trypsin-ethylenediaminetetraacetic acid and counted. The 
mean numbers of unlabeled cells were taken as 100%, and the 
mean numbers of labeled cells were expressed as percentages 
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relative to the 100% control. All experiments were done 
in triplicate and performed on cells from three different 
cultures. The viability of rat MSCs and human chondrocytes 
was determined using the trypan blue (0.1 weight percent) 
exclusion test.
Labeling efficiency and staining intensity
The iron oxide-labeled cells were fixed in 4% parafor-
maldehyde in 0.1 M phosphate buffer (pH 7.4) for 30 minutes, 
washed, and stained for iron to produce ferric ferrocyanide 
(Prussian Blue). Nuclei were counterstained with nuclear fast 
red (Sigma-Aldrich). Labeling efficiency was determined by 
manually counting the number of Prussian Blue-stained and 
unstained cells in five optical fields from each plate using an 
Axioplan® Imaging II microscope at 100× magnification 
and a 10×/0.75 objective lens, an AxioCam® digital camera, 
and AxioVision® 4 software (Carl Zeiss AG, Oberkochen, 
Germany). The intensity of Prussian Blue-stained cells 
was measured colorimetrically. The scanned images with 
manually labeled cells were processed by the MATLAB® 
6.0 Image Processing Toolbox™ (MathWorks, Natick, 
MA). Before the analysis, the colorimetric scale from the 
image colors corresponding to the increasing intensities of 
the Prussian Blue staining of the cells was validated. Each 
Prussian Blue-stained cell in the image was then processed 
and the intensity of the cytoplasmic staining determined as 
the intensity of the color of the cytoplasm on the scale. As 
a result, two parameters were obtained: (1) the presence or 
absence of a label inside the cells expressed as the percentage 
of labeled cells and (2) the amount of label inside the cells, 
which correlates with the intensity of the staining.
Cell differentiation
Rat MSCs were labeled with HA-γ-Fe2O3 and DPA-HA-γ-Fe2O3 
nanoparticles or the commercial contrast agent Endorem. The 
cells were incubated with the nanoparticles at a concentration 
of 15.4 µg iron/mL media. After 72 hours of incubation, the 
contrast agents were washed out by removing the medium and 
rinsing the cell monolayer three times with PBS.
To induce chondrogenesis, the labeled cells were harvested, 
transferred to polypropylene tubes, and differentiated in pellet 
cultures (250,000 cells/pellet) in freshly prepared serum-free 
medium containing DMEM, 0.1 µM dexamethasone (Sigma-
Aldrich), hTGF-β1 (10 ng/mL; Millipore Corporation, 
Billerica, MA), 0.05 mM L-ascorbic acid (Sigma-Aldrich), 
1% ITS+ Universal Culture Supplement (BD Biosciences, 
San Jose, CA) and Primocin™ (100 µg/mL; Lonza Cologne 
GmbH, Cologne, Germany). The tubes were incubated at 
37°C in 5% carbon dioxide. The medium was changed twice 
a week. Chondrogenic pellets were harvested after 20 days 
in culture, fixed with 4% paraformaldehyde, embedded in 
paraffin blocks, cut into 5 µm sections, and stained with Alcian 
Blue and Prussian Blue using standard methods.
MRI relaxometry
MRI relaxometry of the coated γ-Fe2O3 nanoparticles was 
performed using a Minispec® 0.5 T relaxometer (Bruker 
Optik GmbH, Ettlingen, Germany). HA-γ-Fe2O3 or DPA-
HA-γ-Fe2O3 colloids were diluted to final concentrations 
of 0.022 mg iron/mL and sonicated for 10 minutes prior 
to the measurement. T2 relaxometry was performed with a 
Carr–Purcell–Meiboom–Gill multispin-echo sequence with 
an echo spacing of 2 milliseconds and repetition time of 
5 seconds. The measured relaxation times were converted to 
relaxivities (reciprocal values of relaxation times T2 related 
to concentration, ie, relaxivity = 1/T2/concentration).
Phantoms containing suspensions of fixed labeled cells 
were prepared by dispersing the suspensions in gelatin to 
eliminate sedimentation of the cells on the bottom of the test 
tube, then measured at 0.5 T (Minispec 0.5 T   relaxometer; 
Bruker) and at 4.7 T (BioSpec® 4.7 T spectrometer; Bruker). 
T2 relaxation times at 0.5 T were measured with the same 
sequence and parameters as stated above. At 4.7 T, a 
  Carr–Purcell–Meiboom–Gill multispin-echo sequence 
with an echo spacing of 8.63 milliseconds and repetition 
time of 5 seconds was used. The sequence provided a set 
of T2-weighted images (with increasing weighting), from 
which T2 relaxation times were calculated. Relaxation rates 
were calculated as the reciprocal values of relaxation times 
related to one million cells per 1 mL.
As superparamagnetic nanoparticles have a markedly 
smaller effect on T1 and are used solely as a T2 contrast agent, 
T1 of the nanoparticles was not measured.
Results and discussion
γ-Fe2O3 was selected as the most stable iron oxide. γ-Fe2O3 
nanoparticles were obtained by the coprecipitation of 
iron(II) and iron(III) chlorides in ammonium hydroxide, 
and the resulting magnetite (FeO⋅Fe2O3) was oxidized to 
γ-Fe2O3 with sodium hypochlorite. The Mossbauer spectra 
published previously confirmed that the iron oxide consti-
tuting the nanoparticles was predominantly γ-Fe2O3.24 TEM 
was used to determine the shape, size, and uniformity of the 
dried nanoparticles. TEM analysis indicated that uncoated 
γ-Fe2O3 particles showed a rather narrow size distribution 
(PDI = 1.30) with an average size of the nanoparticles of 
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Figure 1 Transmission electron micrograph of (A) neat maghemite and dopamine-hyaluronate-maghemite nanoparticles, (B) Run IIIA/1 (dopamine-hyaluronate/maghemite = 
0.11  weight/weight;  dopamine/hyaluronate  =  0.0075  weight/weight),  and  (C)  Run  IIIA/3  (dopamine-hyaluronate/maghemite  =  0.3  weight/weight;  dopamine/hyaluronate  = 
0.0075 weight/weight).
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Figure 2 Size-exclusion chromatogram of dopamine-hyaluronate in 0.3 M ammonium 
acetate buffer (pH 6.5). Evaporative light scattering detection (solid line) and diode 
array detection at 256 nm (dashed line).
Abbreviations: t, time; U, voltage.
10.7 nm (Figure 1A). The Dh and zeta potential of colloidal 
γ-Fe2O3 were estimated using dynamic light scattering at pH 
∼8. Dh was 83.7 ± 0.6 nm and PI was 0.129 ± 0.006, confirm-
ing the above-mentioned relatively narrow size distribution, 
and the zeta potential reached −53.4 ± 0.8 mV , reflecting good 
colloidal stability. The difference in particle size measured 
with TEM and dynamic light scattering can be ascribed to 
the dynamic fluctuations of colloidal nanoparticles in com-
parison with the dried state and also to the different statistical 
methods used in the two kinds of measurements.
Modification of HA
In an attempt to obtain a DPA-HA associate, conventional N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride/
DPA chemistry was investigated in an HA (molecular weight: 
∼300,000) solution at ten different pH values ranging from 
5–10. A small amount of sodium metabisulfite (Na2S2O5) 
was added to avoid the irreversible oxidation of DPA. 
Coupling was also studied with dicyclohexylcarbodiimide and 
diisopropylcarbodiimide; both agents were combined with a 
N-hydroxysuccinimide in a water/N,N-dimethylformamide, 
(1/3 volume/volume) mixture. Another technique using 
N,N,N′,N′-tetramethyl-O-(N-succinimidyl)uronium 
hexafluorophosphate was tested as well. However, the 
formation of a covalent bond between HA and DPA was never 
confirmed by size exclusion chromatography (Figure 2). In 
the chromatogram, the main signal recorded by the diode 
array detection ultraviolet detector (256 nm) was that of DPA 
(elution time 13 minutes), while signals in the area of high 
molecular weight compounds were absent. Signals recorded by 
the evaporative light scattering detector at elution times of 2.5, 
5, and 9 minutes typical for high molecular weight compounds 
were ascribed to HA. This is contrary to information from 
reports in which the formation of a covalent bond between   
HA and DPA was assumed according to nuclear magnetic 
resonance spectra.18,25,26 Carbodiimides, thus, were not found 
to be suitable coupling agents to covalently attach DPA to HA. 
Nevertheless, the reaction between the amine groups of DPA 
and the carboxyl groups of HA yielded an ionic associate 
(Figure 3) as confirmed by elemental analysis; compared 
with HA, nitrogen content was increased in the DPA-HA 
associate (Table 1).
Coating of γ-Fe2O3 nanoparticles  
with DPA, HA, and DPA-HA associate
Modifying the surface of iron oxide nanoparticles is a common 
strategy to enhance the cellular uptake of nanoparticles. 
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In the present study, HA was intentionally included as a modi-
fying agent to provide a protective shell preventing particle 
aggregation, while bidentate DPA should serve as an anchoring 
moiety. It is an advantage of DPA that the catechol derivatives 
tightly bind onto the surface of iron oxide particles,27 resulting 
in the formation of DPA-γ-Fe2O3 complexes. In contrast, HA 
does not show such a strong interaction with γ-Fe2O3. The reac-
tive amino groups of DPA can then act as coupling links for 
further association with modifying or cell targeting agents.28 In 
this report, an ionic DPA-HA associate was first prepared and 
added to γ-Fe2O3 nanoparticles, with DPA being attached to iron 
oxide via hydroxyl groups,29 while amino groups associated HA 
(Figure 3). According to TEM, the size of the DPA-HA-γ-Fe2O3 
particles was between 7.6–9.5 nm (Figure 1B and C), ie, almost 
the same as that of neat particles. The PDI was 1.26–1.34, which 
is in accordance with the PDI of neat particles.
Several groups of DPA-γ-Fe2O3, HA-γ-Fe2O3, and DPA-
HA-γ-Fe2O3 nanoparticles were prepared differing in their 
composition (Table 2). Coatings by neat DPA (Group I) or 
neat HA (Group II) were used as controls and compared 
with DPA-HA-γ-Fe2O3 nanoparticles (Group III) prepared at 
three different DPA/HA ratios; they were denoted as IIIA–C 
(Table 2). In each group, three samples with a constant 
concentration of γ-Fe2O3 and an increasing concentration 
of DPA-HA associate (or neat DPA or HA) were prepared 
(Table 2). Four parameters were measured as functions of 
the DPA/γ-Fe2O3, HA/γ-Fe2O3, and DPA-HA/γ-Fe2O3 mass 
ratios: Dh, PDI, zeta potential, and pH.
With an increasing HA/γ-Fe2O3 or DPA-HA/γ-Fe2O3 ratio, 
the Dh and PDI increased, probably due to the thicker shell; at 
the same time, the zeta potential and pH decreased (Table 2). 
The zeta potential is an indicator of the colloidal stability 
of magnetic nanoparticles in an aqueous medium. The high 
negative electric charge on the surface of the HA-γ-Fe2O3 
nanoparticles (Runs I/1, I/2, II/1–3, and III) possessing a zeta 
potential in the range between −48 mV and −79 mV prevented 
their aggregation in water due to the repulsion among the 
particles. This negative charge was provided by the ionized 
carboxylic groups of HA, ensuring the colloidal stability 
of the HA-γ-Fe2O3 and DPA-HA-γ-Fe2O3 dispersions. At a 
high DPA/γ-Fe2O3 ratio (Run I/3), the zeta potential already 
approached zero (−7 mV) due to the positive charge of the 
large amounts of DPA; as a result, colloidal stability was 
lost. Aggregation was also observed with DPA-HA-γ-Fe2O3 
particles Run IIIC/3, characterized by a high DPA content 
in the DPA-HA associate. This was probably due to the 
relatively high zeta potential of the discrete particles (Run 
I/3, Table 2) caused by the fast complexation of small posi-
tively-charged DPA molecules to their surface. In contrast, 
bulky negatively-charged HA was exposed on the surface of 
particle aggregates, thus inducing the high negative charge 
of DPA-HA-γ-Fe2O3 Run IIIC/3 (−78 mV; Table 2). The par-
ticle size decreased in the sequence III/A . III/B . III/C; 
in the same sequence DPA/HA increased, ie, the number of 
anchoring groups was higher, thus inducing a more compact 
DPA-HA layer.
Cell growth and viability
In order to evaluate the acute toxicity of DPA-HA-coated 
γ-Fe2O3 nanoparticles, the growth and viability of labeled rat 
MSCs were examined. Unlabeled rat MSCs doubled their 
population within 48 hours, while cells labeled with coated 
nanoparticles grew slightly slower (70%–100% of control). 
The slowest growth (54% ± 4%) was observed in cells labeled 
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Figure 3 Association of hyaluronate with dopamine.
Table  1  Elemental  analysis  of  hyaluronate  and  dopamine-
hyaluronate associate
Elemental analysis (wt%) C H N Na
HA 39.82 5.30 3.19 6.43
DPA-HA associate 39.82 5.79 3.85 2.67
Abbreviations: C, carbon; DPA, dopamine; H, hydrogen; HA, hyaluronate; N, nitrogen; 
Na, sodium; wt%, weight percent.
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Figure 4 Labeling efficiency is expressed as the percentage of rat bone marrow mesenchymal stem cells labeled with hyaluronate-maghemite nanoparticles Runs II/1–3, 
dopamine-maghemite nanoparticles Runs I/1–3, dopamine-hyaluronate-maghemite nanoparticles Runs IIIA/1–3, IIIB/1–3, and IIIC/1–3, neat maghemite, and Endorem® 
(guerbet, Roissy, France). 
Notes: A colloid containing 15.4 µg of iron per mL was added to the culture media for 72 hours. All experiments were done in triplicate, counting five optical fields from 
each well (n = 15).
Abbreviation: γ-Fe2O3, maghemite.
with uncoated γ-Fe2O3 nanoparticles. The viability of rat MSCs 
was tested using the trypan blue exclusion test. Varying the 
composition of the coating and increasing the concentration 
of DPA-HA did not substantially influence rat MSC viability 
(Table 2). A small decrease in viability (83.5% ± 0.5%) was 
observed in cells labeled with uncoated γ-Fe2O3 nanoparticles. 
The viability of Endorem-labeled rat MSCs, considered the 
gold standard among commercial contrast agents used for cell 
labeling, reached about 85%. These results are comparable 
with those from previous studies.30 When labeling chondro-
cytes, differences in growth and viability between labeled and 
unlabeled cells were not observed.
Cell labeling efficiency
The uptake of nanoparticles into rat MSCs (expressed as 
the percentage of labeled cells) was investigated using 
Prussian Blue staining. The cells were evaluated as to 
whether they were stained or not; the intensity of staining 
was not considered. In each group (Runs I, II, III), the highest 
percentage of labeled cells was obtained with nanoparticles 
containing the highest DPA concentration (Figure 4). Over 
90% labeled cells was achieved with DPA-HA-γ-Fe2O3 
nanoparticles Run IIIC/3 and DPA-γ-Fe2O3 nanoparticles 
Run I/3. However, the latter particles formed clumps and also 
adhered to the cell surface and the bottom of the culture well. 
A labeling efficiency superior to that obtained with the 
commercial contrast agent Endorem (66%) was also achieved 
with nanoparticles Run IIIA/3 (74%) and I/2 (76%). 
A labeling efficiency less than that obtained with Endorem 
was observed with uncoated γ-Fe2O3 (56%) and nanoparticles 
Run IIIA/1 (35%), Run IIIA/2 (18%), and Run IIIB/2 (52%). 
The remainder of the nanoparticles gave results comparable 
with Endorem within the range of 61%–71%.
To compare how much label was taken into the cells, the 
distribution of the intensity of Prussian Blue staining inside 
the labeled cells was studied (Figure 5). The highest intensity 
of Prussian Blue staining was detected in cells labeled with 
DPA-HA-γ-Fe2O3 nanoparticles Run IIIC/3. Similar results 
were obtained with DPA-γ-Fe2O3 Run I/3; however, these 
particles adhered to the cell surface and are therefore not 
shown in Figure 5. There were no marked differences among 
the rest of the coated nanoparticles, and a representative curve 
(Run II/3) is presented in Figure 5. The lowest intensity of 
Prussian Blue staining was observed in cells labeled with 
Endorem (Figure 5) or neat γ-Fe2O3 (not shown).
Representative histological images of Prussian Blue staining 
are shown in Figure 6. They underline the results described 
in Figures 4 and 5. It was obvious that the bulky, negatively-
charged HA molecule was internalized in cells less efficiently 
than positively-charged poly(L-lysine)-coated nanoparticles. 
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HA-γ-Fe2O3 nanoparticles exhibited a low cellular uptake, 
presumably because of HA desorption (Figure 6B). Only 
HA-γ-Fe2O3 nanoparticles Run II/3 (Figure 6C), containing 
the highest concentration of HA, were comparable with 
Endorem (Figure 6G) or neat γ-Fe2O3 (Figure 6H). The fact 
that DPA, which induces the adsorption of serum proteins, 
played an important role in cell internalization was confirmed 
by microscopic observation of Prussian Blue-stained rat MSCs 
labeled with DPA-γ-Fe2O3 nanoparticles (Figure 6A). DPA 
renders γ-Fe2O3 nanoparticles with positive charges, which 
is desirable, while at the same time maintaining a small size 
favorable for internalization by the cells. It can be supposed that 
the more DPA on the particles, the greater the aggregation with 
proteins in the culture medium. Such aggregates are too large 
to be internalized by the cells. At a high concentration of DPA 
(Run I/3), the particles already stuck to the cell membranes 
and to the well bottom. Therefore, the highest concentration 
that could be safely used for cell labeling was that used in 
Run I/2. In contrast, HA acts as a steric barrier (protective 
shell) minimizing nanoparticle aggregation. Figure 6D–F 
nicely document the synergistic effect of HA and DPA. In the 
group including DPA-HA-γ-Fe2O3 nanoparticles Run IIIC, the 
efficiency as well as the intensity of the cell labeling increased 
with increasing DPA concentration.
Superior results were obtained with the labeling of human 
chondrocytes (Figure 7A). From each group only Runs II/3, 
IIIB/3, and IIIC/3 were tested, since these nanoparticles 
performed best in rat MSC labeling. All tested nanoparticles 
achieved a labeling efficiency over 90%; the highest labeling 
intensity was obtained with DPA-HA-γ-Fe2O3 nanoparticles 
Run IIIC/3, followed by HA-γ-Fe2O3 Run II/3 and DPA-HA-
γ-Fe2O3 Run IIIB/3. Similar results were obtained in the distri-
bution of the intensity of Prussian Blue staining (Figure 7B). 
In contrast to the results obtained in rat MSCs, HA-γ-Fe2O3 
nanoparticles Run II/3 showed a higher labeling efficiency, 
as well as staining intensity, than DPA-HA-γ-Fe2O3 nano-
particles Run IIIB/3. Histological images (Figure 8) clearly 
support the data shown in Figure 7. In contrast to the results 
observed in rat MSCs, DPA-HA-γ-Fe2O3 nanoparticles Run 
IIIC/3 already aggregated and also adhered to the cell surface 
(Figure 8D). As MSCs and chondrocytes possess receptors 
for HA (CD44), iron oxide uptake is therefore most likely a 
receptor-mediated process.
Cell differentiation into chondrogenic 
phenotypes
For the use of stem cells in cell therapies, their abil-
ity to differentiate in the presence of superparamagnetic 
Endorem
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Figure 5 In the MATLAB® 6.0 Image Processing Toolbox™ (MathWorks, Natick, MA), the color scale of Prussian Blue staining was precomputed from unstained and 
maximally stained nanoparticles (without cells) in CIE L*a*b color space and experimentally validated on images with stained cells. 
Notes: The cells in each image were manually labeled, and for each cell the staining intensity as an index on the precomputed color scale was averaged. As a result, the 
figure shows representative curves of the distribution of the intensity of Prussian Blue staining (X axis) of rat bone marrow mesenchymal stem cells labeled with dopamine-
hyaluronate-maghemite nanoparticles Run IIIC/3, hyaluronate-maghemite nanoparticles Run II/3, and Endorem® (guerbet, Roissy, France). The Y axis shows the percentage 
of cells for each labeling intensity.
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Figure 6 Microscopic observation of Prussian Blue-stained rat bone marrow mesenchymal stem cells labeled with (A) dopamine-maghemite nanoparticles Run I/3,   
(B) hyaluronate-maghemite nanoparticles Run II/1 and (C) Run II/3, dopamine-hyaluronate-maghemite nanoparticles (D) Run IIIC/1, (E) Run IIIC/2, and (F) Run IIIC/3,   
(G) Endorem® (guerbet, Roissy, France), and (H) neat maghemite. 
Notes: Cell nuclei are counterstained with hematoxylin. Scale bar 25 µm.
nanoparticles is crucial. Although iron oxide nanoparticles 
are generally considered as safe, there are several reports 
in the literature that differently coated superparamagnetic 
iron oxide   particles negatively affect the chondrogenic 
differentiation of MSCs.31,32 Some superparamagnetic iron 
oxides are suspected to produce reactive oxygen species33 
or affect the cytoskeleton and cell membrane.34 Since HA 
is present in cartilage, the chondrogenic differentiation of 
rat MSCs labeled with HA-γ-Fe2O3 nanoparticles Run II/3, 
DPA-HA-γ-Fe2O3 nanoparticles Run IIIC/3, and Endorem was 
tested. After 20 days of incubation in chondrogenic medium, 
the cells labeled with DPA-HA-γ-Fe2O3 nanoparticles Run 
IIIC/3 and with Endorem formed solid chondrogenic pellets 
with positive Alcian Blue staining, confirming differentiation 
into chondrocytes (Figure 9A and C). In contrast, the cells 
labeled with HA-γ-Fe2O3 nanoparticles Run II/3 were not able 
to form a proper pellet (Figure 9E) and no differentiation was 
observed. Prussian Blue staining confirmed that the labeled 
cells contained iron (Figure 9B–F). The amount of iron was 
apparently higher in cells and pellets containing DPA-HA-γ-
Fe2O3 nanoparticles Run IIIC/3 and HA-γ-Fe2O3 nanoparticles 
Run II/3 than in Endorem-labeled pellets, which corresponded 
to the higher labeling efficiency of these nanoparticles com-
pared to Endorem. The results show that the chondrogenic 
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differentiation of MSCs could be impaired by HA-γ-Fe2O3 
nanoparticles. The exact effect of HA on chondrogenic dif-
ferentiation is not clear. Ng et al showed that exogenous 
HA of molecular weight 2.5 × 105 Da, when added to the 
culture medium of an explant culture of articular cartilage, 
inhibited both aggrecan and HA synthesis in a concentration-
dependent manner.35 It can be speculated that residual bulky 
HA molecules remaining in the media or attached to the cell 
surface prevent pellet formation and thus impair chondrogenic 
  differentiation. In contrast, the presence of DPA not only 
leads to a higher amount of label inside the cells, but also has 
no negative effect on pellet formation and subsequently on 
chondrogenic differentiation, most probably due to the better 
internalization of the nanoparticles inside the cells.
MRI relaxometry
Contrast in an MRI depends not only on the proton density 
of the measured object, but (in the case of T1-weighted or 
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Figure 7 (A) Labeling efficiency of human chondrocytes expressed as the number of Prussian Blue-positive cells. (B) Distribution of Prussian Blue labeling intensity in human 
chondrocytes.
Figure 8 Prussian Blue staining of human chondrocytes labeled with (A) Endorem® (guerbet, Roissy, France), (B) dopamine-hyaluronate-maghemite nanoparticles Run IIIB/3, 
(C) hyaluronate-maghemite nanoparticles Run II/3, and (D) dopamine-hyaluronate-maghemite nanoparticles Run IIIC/3. 
Notes: Cell nuclei are counterstained with nuclear fast red. Scale bar 25 µm.
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Figure 9 To determine whether hyaluronate molecules, which are also present in the cartilage extracellular matrix, can affect chondrogenic differentiation, rat bone marrow 
mesenchymal stem cells labeled with (A and B) dopamine-hyaluronate-maghemite nanoparticles Run IIIC/3, (C and D) Endorem® (guerbet, Roissy, France), and (E and F) 
hyaluronate-maghemite nanoparticles Run II/3 were differentiated into a chondrogenic phenotype. 
Notes: The left column shows staining for Alcian Blue (a marker of chondrogenic differentiation), while the right column represents Prussian Blue staining. Iron is visible as 
(A, C and E) brown or (B, D and F) blue deposits.
T2-weighted images) predominantly on relaxation times. 
Relaxometry enables the direct measurement of relaxivi-
ties (ie, the reciprocal values of relaxation times related to 
concentration), which reflect both the concentration of 
paramagnetic or superparamagnetic substances and water 
exchange, which also varies with the size and solubility of 
the given magnetic particles.
Table 2 summarizes the relaxivities of DPA-γ-Fe2O3, 
HA-γ-Fe2O3, and DPA-HA-γ-Fe2O3 nanoparticles. DPA-
γ-Fe2O3 nanoparticles obtained at a low DPA/γ-Fe2O3 ratio 
(Run I/1) displayed a higher relaxivity than did neat γ-Fe2O3. 
At higher DPA/γ-Fe2O3 ratios (Runs I/2 and I/3), relaxivity 
decreased. The authors speculate that a higher DPA/γ-Fe2O3 
ratio may lead to greater nanoparticle aggregation. During 
aggregation, contacts between the nanoparticles and water 
molecules are reduced due to the exclusion of water from 
the interior of the aggregates.
The relaxivity of HA-γ-Fe2O3 nanoparticles (Group II) was 
substantially higher than that of DPA-γ-Fe2O3 nanoparticles 
and increased with an increasing HA/γ-Fe2O3 ratio (Figure 10). 
The dependence approximately followed an exponential fit 
(solid line in Figure 10, calculated without the last point). The 
authors hypothesize that with an increasing HA/γ-Fe2O3 ratio, 
the amount of water surrounding the particles increased due 
to the extremely high hydrophilicity of HA. HA carries large 
amounts of water molecules in the close vicinity of γ-Fe2O3 
particles, thus increasing MRI contrast. However, at very 
high HA/γ-Fe2O3 ratios (HA/γ-Fe2O3 ∼0.6 weight/weight and 
more), HA-γ-Fe2O3 nanoparticles sedimented and relaxivity 
decreased (last point in Figure 10).
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Table 3 Relaxation rates of rat bone marrow mesenchymal stem 
cells labeled with surface-modified maghemite nanoparticles
R2 (s-1/106  
rMSCs/mL)  
at 0.5 T
R2 (s-1/106  
rMSCs/mL)   
at 4.7 T
HA-γ-Fe2O3 II/3 3.7 ± 0.4   7.8 ± 0.3
DPA-HA-γ-Fe2O3 IIIB/3 6.7 ± 0.1 11.6 ± 0.8
DPA-HA-γ-Fe2O3 IIIC/3 3.3 ± 0.3   5.8 ± 1.0
Abbreviations: DPA, dopamine; γ-Fe2O3, maghemite; HA, hyaluronate; R2, relaxation 
rates; rMSCs, rat bone marrow mesenchymal stem cells.
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Figure  10  Dependence  of  the  relaxivity  of  hyaluronate-maghemite  nanoparticles   
group II on the hyaluronate/maghemite ratio. 
Note: The solid line represents an exponential fit.
Abbreviations: Fe, iron; HA, hyaluronate; γ-Fe2O3, maghemite; r2, relaxivity.
DPA-HA-γ-Fe2O3 nanoparticles revealed a similar 
relaxivity as did HA-γ-Fe2O3 nanoparticles, ie, relaxivity 
was substantially higher than in nanoparticles associated 
with DPA only. This confirmed the importance of HA for 
ensuring the stability of the colloid and for water exchange, 
which plays a crucial role in water relaxation.
The relaxation rates of gelatin containing suspensions 
of labeled cells and measured at 0.5 and 4.7 T are shown in 
Table 3. The relaxation rates of the cell suspensions depended 
not only on the relaxivity of the nanoparticles used for cell 
labeling, but mainly on the number of particles internalized 
by the cells. Although HA-γ-Fe2O3 nanoparticles exhibited the 
highest relaxivities (because HA ensured colloidal stability 
and excellent water exchange), the highest relaxation rate was 
found in cells labeled with DPA-HA-γ-Fe2O3 nanoparticles 
at a DPA/HA ratio = 0.01936 (weight/weight) (Table 3). It 
could thus be hypothesized that DPA associated at a moderate 
concentration substantially improved cellular uptake.
Nevertheless, at a higher DPA/HA ratio (0.03842 
weight/weight), relaxivity again decreased, probably due to 
aggregation leading to sedimentation, which lowered both 
the relaxivity of the nanoparticles and also the cellular uptake 
of the particles.
Conclusion
The surface properties of γ-Fe2O3 nanoparticles play a key 
role in their permeation through the cell membrane. HA 
was therefore associated with a DPA anchoring group 
and the resulting coating was used for the efficient surface 
modification of γ-Fe2O3 nanoparticles. While the DPA 
moiety had a high affinity for the γ-Fe2O3 surface, because 
the catechol groups of DPA formed stable chemical bonds 
on the iron oxide surface, HA ensured colloidal stability and 
boosted the relaxivity of the iron oxide. Surface-modified 
magnetic nanoparticles were used for rat MSC and 
chondrocyte labeling. Even though γ-Fe2O3 nanoparticles 
coated with DPA alone penetrated into the cells due to the 
positive DPA charge, the best results were obtained with 
the formation of a DPA-HA ionic associate on the particles. 
Viability assays revealed no significant differences in either 
the proliferation or viability of cells labeled with DPA-
HA-γ-Fe2O3 nanoparticles compared to unlabeled cells. 
A low concentration of DPA-HA-γ-Fe2O3 nanoparticles was 
sufficient to achieve clearly visible contrast in MRI. DPA 
was involved in the internalization of the nanoparticles by 
the cells, and its concentration was important to achieve 
good cell labeling. The presence of HA on the surface of 
the nanoparticles may mediate their penetration into cells 
via the cell membrane and facilitate their uptake by MSCs. 
The percentage of Prussian Blue-stained cells was highest 
(85%) in cells labeled with DPA-HA-γ-Fe2O3 nanoparticles 
Run IIIC/3. Thus, the association of DPA to the HA chain and 
the subsequent anchoring of DPA-HA on the γ-Fe2O3 surface 
via hydroxyl groups played a pivotal role in cellular uptake 
and MRI. Similarly, the chondrogenic differentiation of 
labeled cells was successfully achieved only with DPA-HA-
γ-Fe2O3 nanoparticles. The advantage of DPA-HA-γ-Fe2O3 
nanoparticles consists in the availability of a large number 
of carboxyl groups for the prospective attachment of target 
molecules, antibodies, proteins, fluorescent labels, therapeutic 
agents (growth hormones), or cancerostatics. At the same 
time, MRI can detect the labeled cells, thus enabling their 
tracking in the tissue, which is important in applications such 
as cell imaging, cell tracking, cell-based therapies, and tissue 
engineering. Such nanoparticles might also be useful for the 
labeling of neurons, glial cells, or cartilage.
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